Macchi, Lorenzo
Bao, Quoc Riccardo
Albertoni, Laura
Fassan, Matteo
Chiminazzo, Valentina
Scarpa, Marco
Spolverato, Gaya
Pucciarelli, Salvatore
Funding for this research was provided by:
Università degli Studi di Padova
Article History
Received: 21 January 2022
Accepted: 18 May 2022
First Online: 18 June 2022
Declarations
:
: All the authors have indicated that they have no conflict of interest to declare. Matteo Fassan received research funding from Astellas Pharma, Macrophage Pharma, and QED Therapeutics and had roles as consultant or advisor for Astellas Pharma, GSK-Tesaro, MSD, Roche, and Astra Zeneca. The other authors have no conflicts of interest to declare regarding the present manuscript.